More from the Author

• Case | HBS Case Collection | September 2014 (Revised October 2020)

  La Ribera Health Department (A)

  Regina E. Herzlinger, Emer Moloney and Daniela Beyersdorfer

  The La Ribera case studies depict an innovative low cost/high quality privately financed hospital model struggling to achieve alignment with the Six Factors. It is reimbursed by the public sector in a Spanish environment whose Consumers, Structure, and Public Policy favor public health care. But the Accountability factor shows it to be the highest quality hospital in the region with 25% lower costs and Spain's Financing is weak.
  The A case (9-315-006) asks: What Business Model elements enabled La Ribera to achieve this level of value? How can it improve on its 1% profit margin and better align itself with the Six Factors? The hospital hired a consulting firm that presented four new options that could potentially increase returns. Which, if any, best fit with the ten elements of its Business Model?
  The B case (9-318-134) contains the dénouement for La Ribera. To order copies of the cases write to HBS Publishing, Boston 02163.

  Keywords: Health Care and Treatment; Business Model; Government and Politics; Programs; Innovation Strategy; Vertical Integration; Health Industry; Europe; Spain;

  Citation:

  Herzlinger, Regina E., Emer Moloney, and Daniela Beyersdorfer. "La Ribera Health Department (A)." Harvard Business School Case 315-006, September 2014. (Revised October 2020.)  View Details

  CiteView DetailsEducatorsPurchase

  Related

• Supplement | HBS Case Collection | May 2018 (Revised October 2020)

  La Ribera Health Department (B): Epilogue

  Regina E. Herzlinger, Emer Moloney and Daniela Beyersdorfer

  The La Ribera case studies depict an innovative low cost/high quality privately financed hospital model struggling to achieve alignment with the Six Factors. It is reimbursed by the public sector in a Spanish environment whose Consumers, Structure, and Public Policy favor public health care. But the Accountability factor shows it to be the highest quality hospital in the region with 25% lower costs and Spain's Financing is weak.
  The A case (9-315-006) asks: What Business Model elements enabled La Ribera to achieve this level of value? How can it improve on its 1% profit margin and better align itself with the Six Factors? The hospital hired a consulting firm that presented four new options that could potentially increase returns. Which, if any, best fit with the ten elements of its Business Model?
  The B case (9-318-134) contains the dénouement for La Ribera. To order copies of the cases write to HBS Publishing, Boston 02163.

  Keywords: trends and opportunities; government; Government programs; Acquisition; Business Model; Business Plan; Trends; Opportunities; Government and Politics; Programs; Health Care and Treatment; Situation or Environment; Health Industry; Insurance Industry; Technology Industry; Spain;

  Citation:

  Herzlinger, Regina E., Emer Moloney, and Daniela Beyersdorfer. "La Ribera Health Department (B): Epilogue." Harvard Business School Supplement 318-134, May 2018. (Revised October 2020.)  View Details

  CiteView Details

  Related

• Case | HBS Case Collection | August 2020 (Revised October 2020)

  1928 Diagnostics: Fighting Antibiotics Resistance

  Ariel D. Stern and Daniela Beyersdorfer

  In 2019, the co-founders of the Swedish medical start-up 1928 Diagnostics, CEO Dr. Kristina Lagerstedt and COO Dr. Susanne Staaf, had to pick the right business model to commercialize their novel technology to hospitals and health care providers. Developed in partnership with research hospitals to help fight the global antibiotic resistance crisis, the firm’s cloud-based technology platform helped partners identify resistant genes and mutations in bacteria more quickly and accurately, allowing for easier outbreak cluster tracking in support of hospital infection control management, as well as better diagnostics and antibiotic selection. By 2019, they had raised $5 million, employed 16 people, and had their tool deployed at 24 partner sites in 10 different countries. Their decisions on which markets to focus on and with which business model would crucially impact the young firm’s chances at successfully converting existing users and attracting new clients.

  Keywords: Health Care and Treatment; Entrepreneurship; Leadership; Science-Based Business; Growth and Development Strategy; Business Growth and Maturation; Business Model; Technology; Health Industry; Medical Devices and Supplies Industry; Technology Industry; Europe; Sweden;

  Citation:

  Stern, Ariel D., and Daniela Beyersdorfer. "1928 Diagnostics: Fighting Antibiotics Resistance." Harvard Business School Case 621-025, August 2020. (Revised October 2020.)  View Details

  CiteView DetailsEducatorsPurchase

  Related